fpft 2216 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
fpft 2216
Fpft 2216, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fpft+2216/FPFT-2216/pm40608931-517-0-24
Average 93 stars, based on 3 article reviews
Fpft 2216, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fpft+2216/FPFT-2216/pm40608931-517-0-24
Average 93 stars, based on 3 article reviews
fpft 2216 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: Development of PDE6D and CK1α Degraders Through Chemical Derivatization of FPFT-2216 Article Snippet: Next day, cells were treated with Article Title: Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation Article Snippet: Thalidomide (T2524, Tokyo Chemical Industry), pomalidomide (P2074, Tokyo Chemical Industry), lenalidomide (#126-06733, FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), thalidomide-O-COOH (HY-103597, MedChemExpress, NJ, USA), CC-122/Avadomide, ( Article Title: Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition. Article Snippet: INTRODUCTION: Molecular glue degraders (MGDs) are an emergent class of small molecules that induce proximity between a target protein and an E3 ubiquitin ligase, causing target protein ubiquitination and degradation.. Clinically active MGDs that repurpose the CRL4CRBN ubiquitin ligase recruit their efficacy targets through a common recognition motif known as the βhairpin Gloop degron, which is a simple secondary structure element with a high prevalence in the human proteome.. The Gloop defines surface features that create overall complementarity to the cereblon (CRBN)–MGD interface and enable proteinprotein interactions that potentially mimic the recognition of an endogenous CRBN substrate. |